{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:01:26Z","timestamp":1769508086090,"version":"3.49.0"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T00:00:00Z","timestamp":1448409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0143783","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T18:49:47Z","timestamp":1448477387000},"page":"e0143783","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hepatic Interferon-\u03bb3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C"],"prefix":"10.1371","volume":"10","author":[{"given":"Ahmad","family":"Amanzada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothea","family":"Fey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth M.","family":"Zeisberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Mihm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,11,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"17","author":"D Lavanchy","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"D Ge","year":"2009","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study","volume":"138","author":"A Rauch","year":"2010","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"V Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Y Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"P Sheppard","year":"2003","journal-title":"Nat Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"SV Kotenko","year":"2003","journal-title":"Nat Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"L Prokunina-Olsson","year":"2013","journal-title":"Nat Genet"},{"key":"ref9","first-page":"583","article-title":"IFN-lambdas","volume":"23","author":"SV Kotenko","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1053\/j.gastro.2011.12.057","article-title":"Effect of IL28B genotype on early viral kinetics during interferon-free treatment of patients with chronic hepatitis C","volume":"142","author":"TW Chu","year":"2012","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJMoa1213557","article-title":"Faldaprevir and deleobuvir for HCV genotype 1 infection","volume":"369","author":"S Zeuzem","year":"2013","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/jgh.12475","article-title":"Role of IL28B for chronic hepatitis C treatment toward personalized medicine","volume":"29","author":"K Matsuura","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.20130012","article-title":"IL28B expression depends on a novel TT\/-G polymorphism which improves HCV clearance prediction","volume":"210","author":"S Bibert","year":"2013","journal-title":"J Exp Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ni.2758","article-title":"The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs","volume":"15","author":"AP McFarland","year":"2014","journal-title":"Nat Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1089\/jir.2013.0117","article-title":"Post-transcriptional regulation of interferons and their signaling pathways","volume":"34","author":"R Savan","year":"2014","journal-title":"J Interferon Cytokine Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/1471-2105-8-428","article-title":"Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool 'CubeX'","volume":"8","author":"TR Gaunt","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/labinvest.3700135","article-title":"Interferon type I gene expression in chronic hepatitis C","volume":"84","author":"S Mihm","year":"2004","journal-title":"Lab Invest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/gene.2015.11","article-title":"Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C: A phenotype-genotype correlation study","volume":"16","author":"M Noureddin","year":"2015","journal-title":"Genes Immun"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1101\/gr.229102. Article published online before print in May 2002","article-title":"The human genome browser at UCSC","volume":"12","author":"WJ Kent","year":"2002","journal-title":"Genome Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e84026","DOI":"10.1371\/journal.pone.0084026","article-title":"Interferon-lambda4 (IFNL4) transcript expression in human liver tissue samples","volume":"8","author":"A Amanzada","year":"2013","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000369973","article-title":"Activation of Type I and Type III Interferons in Chronic Hepatitis C","volume":"7","author":"S Mihm","year":"2015","journal-title":"J Innate Immun"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1089\/jir.2013.0136","article-title":"IFN-lambda4: the paradoxical new member of the interferon lambda family","volume":"34","author":"TR O'Brien","year":"2014","journal-title":"J Interferon Cytokine Res"},{"key":"ref23","article-title":"Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance","author":"TR O'Brien","year":"2015","journal-title":"J Hepatol."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0143783","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T23:02:45Z","timestamp":1540249365000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0143783"}},"subtitle":[],"editor":[{"given":"Golo","family":"Ahlenstiel","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,25]]},"references-count":23,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0143783","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,25]]}}}